Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.56
+0.82 (10.59%)
Nov 24, 2025, 4:00 PM EST - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $27.21 million as of November 25, 2025. Its market cap has decreased by -32.36% in one year.
Market Cap
27.21M
Enterprise Value
-1.23M
1-Year Change
-32.36%
Ranking
Category
Stock Price
$8.56
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $27.21M, a decrease of -97.16%. That is a compound annual growth rate of -46.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 27.21M | -22.32% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.53B |
| Johnson & Johnson | 493.45B |
| AbbVie | 411.36B |
| UnitedHealth Group | 291.99B |
| AstraZeneca | 280.49B |
| Merck & Co. | 252.12B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 224.59B |